203 related articles for article (PubMed ID: 17627890)
1. Mechanisms of PDL1-mediated regulation of autoimmune diabetes.
Guleria I; Gubbels Bupp M; Dada S; Fife B; Tang Q; Ansari MJ; Trikudanathan S; Vadivel N; Fiorina P; Yagita H; Azuma M; Atkinson M; Bluestone JA; Sayegh MH
Clin Immunol; 2007 Oct; 125(1):16-25. PubMed ID: 17627890
[TBL] [Abstract][Full Text] [Related]
2. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
Shameli A; Clemente-Casares X; Wang J; Santamaria P
J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
[TBL] [Abstract][Full Text] [Related]
3. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
[TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
5. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
6. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
7. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
8. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells.
Westendorf AM; Fleissner D; Deppenmeier S; Gruber AD; Bruder D; Hansen W; Liblau R; Buer J
Gastroenterology; 2006 Aug; 131(2):510-24. PubMed ID: 16890605
[TBL] [Abstract][Full Text] [Related]
10. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
Balasa B; Van Gunst K; Sarvetnick N
Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.
Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B
Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487
[TBL] [Abstract][Full Text] [Related]
12. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
13. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E
Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066
[TBL] [Abstract][Full Text] [Related]
14. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
15. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
[TBL] [Abstract][Full Text] [Related]
16. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes.
Gonzalez A; Andre-Schmutz I; Carnaud C; Mathis D; Benoist C
Nat Immunol; 2001 Dec; 2(12):1117-25. PubMed ID: 11713466
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of autoimmune diabetes mellitus to athymic rats: synergy of CD4+ and CD8+ T cells and prevention by RT6+ T cells.
Whalen BJ; Greiner DL; Mordes JP; Rossini AA
J Autoimmun; 1994 Dec; 7(6):819-31. PubMed ID: 7888038
[TBL] [Abstract][Full Text] [Related]
18. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]